Water-as-a-Service vs Ownership: Total Cost of Water Analysis

The question most industrial finance teams get wrong is not whether water treatment costs money. It is whether they have correctly accounted for all the money it costs. The 15-year net present value comparison between owning and operating a water treatment plant versus contracting it under a Water-as-a-Service model looks deceptively simple on a spreadsheet: add up CAPEX, add up annual OPEX, discount to today, compare. In practice, the ownership model carries four categories of cost that do not appear in most internal financial models, and the WaaS model carries contract risks that do not appear in the provider's pricing sheet. This article cuts through both sets of omissions.

This is a financial analysis, not an operational one. The question of which O&M model is operationally right for your facility, whether to run in-house, outsource to a contractor, or transfer operations to a WaaS provider, is covered in depth in Water Treatment Plant O&M: Build vs Buy vs Outsource. This article assumes you have a facility that needs water treatment and asks a different question: what do you actually pay over 15 to 20 years in each model, line by line, and which model is cheaper once you account for the costs that rarely make it into the initial financial case?

The target reader is a CFO, capital projects director, or plant manager making a 10 to 20 year commitment. The numbers in this article are drawn from European and North American industrial water treatment projects across food and beverage, pharmaceuticals, chemicals, and general manufacturing. Where ranges are given, the lower end reflects straightforward plants in low-regulatory-complexity environments; the upper end reflects complex plants, tight effluent standards, or multiple treatment stages.

What WaaS actually is (and what it is not)

Water-as-a-Service is a procurement and financing model, not a technology. In a WaaS arrangement, a specialist water treatment provider designs, builds, owns, and operates a treatment plant at your facility. You pay a service fee, typically priced per cubic metre of treated water or as a fixed monthly availability fee, and the provider retains ownership of the physical plant throughout the contract. At contract end, the plant may transfer to you at a defined book value, be renewed under a new contract, or be removed by the provider.

WaaS is not outsourced O&M. In outsourced O&M, you own the plant and contract a specialist to operate it for you. You bear the capital risk. If the membranes reach end-of-life early, you fund the replacement. If the technology becomes obsolete, you own the obsolete asset. WaaS transfers those risks to the provider, who assumes them in exchange for a longer contract and a higher unit cost.

WaaS is not equipment leasing. Equipment leasing gives you physical possession of the asset for a period in exchange for lease payments, with an option to purchase at end of term. WaaS includes the asset, the operation, the maintenance, the consumables, and the performance guarantee. You are buying treated water, not financing an asset. The provider's obligation is water quality and volume at the agreed specification. How they deliver it, and with what technology, is their problem.

WaaS is not always available. Credible WaaS providers will not accept every project. They require sufficient volume to justify the capital exposure (typically above 200 m3/day for process water, sometimes higher for more complex treatment trains), a site with a stable operational future, and a creditworthy counterparty who can guarantee payment over a 15 to 20 year contract. Sites with uncertain futures, highly variable demand, or complex feedwater conditions that increase operational risk may find WaaS providers unwilling to quote, or quoting at rates that reflect the risk rather than the standard commercial model.

The International Water Association's framework for water service delivery models distinguishes between asset-owning utilities, service-contract models, and full-service concession models. Industrial WaaS sits closest to the full-service concession model: the provider takes on the full capital, operational, and performance risk for the water system in exchange for a long-term contracted revenue stream. Understanding this framing matters because the financial logic of WaaS pricing follows concession economics, not equipment economics.

The four cost categories ownership models miss

The ownership financial model that gets presented to investment committees typically captures CAPEX, annual staff cost, consumables (chemicals, membranes, filter media), and energy. It misses four categories of cost that are real, quantifiable, and material to the 15-year total cost of ownership comparison.

Category 1: Capital replacement cycles. A water treatment plant has a design life, but the individual components within it do not all last the same amount of time. Membranes in a standard industrial RO system have a commercial life of 3 to 5 years under normal operating conditions before performance decline makes replacement economically necessary. Ion exchange resin in a mixed bed or softener application requires partial or full replacement every 4 to 8 years depending on the service duty. UV lamps in disinfection systems have 12-month lamp life under continuous duty. Pump mechanical seals typically run 3 to 5 years before overhaul. None of these costs appear in the initial CAPEX model. Together, they add 15 to 30% to the 15-year total cost of ownership relative to the opening capital cost. A plant with an initial equipment capital cost of 1.2 million euros will require an additional 180,000 to 360,000 euros in capital replacement over a 15-year life before any major refurbishment. Most ownership financial models provision for 0 to 50% of this cost.

Category 2: Technology and regulatory upgrade cost. Industrial wastewater discharge regulations do not stay constant over 15-year periods. European industrial emissions legislation has tightened progressively since 2010 and is expected to continue tightening, particularly for nutrients (nitrogen, phosphorus), micropollutants, and certain industrial chemicals. A plant designed to 2026 consent conditions may require additional treatment stages by 2033. The cost of retrofitting a tertiary treatment stage, adding an advanced oxidation process, or upgrading to tighter limits can run 200,000 to 800,000 euros at the time of installation. This cost is entirely the owner's problem. Under WaaS, the provider bears the risk of regulatory upgrade cost within the performance specification agreed in the contract.

Category 3: Compliance event costs. Even well-run in-house operations experience compliance events: an out-of-specification discharge, a permit breach, a licence condition failure. The financial cost of a compliance event combines the regulatory fine (typically 10,000 to 100,000 euros in Europe for a first significant breach), the remediation cost, the cost of increased regulatory scrutiny (more frequent audits, reporting requirements, licence conditions), and the management time diverted to regulatory response. Studies on industrial water risk management by the European Environment Agency indicate that industrial facilities with complex water treatment systems experience compliance events at a higher frequency than facilities with simple systems, and that in-house operations without specialist support have materially higher event frequencies than professionally managed operations. The expected value of compliance event costs over 15 years should appear in every ownership financial model. It rarely does.

Category 4: Opportunity cost of management capacity. Water treatment at an industrial facility is not a core business activity. The management time, board attention, and organisational energy consumed by water treatment problems, whether recruiting operators, managing a compliance event, specifying a capital replacement project, or handling a vendor dispute, is diverted from activities that generate value in the core business. This cost is difficult to quantify in a spreadsheet, but it is real. Senior engineering or operations time at a manufacturing facility costs 150 to 300 euros per hour fully loaded. A mid-cycle membrane replacement project consumes 40 to 80 hours of senior technical and commercial management time. A compliance event consumes 100 to 300 hours. These costs are opportunity costs, not cash costs, and they are systematically excluded from every financial model. WaaS converts most of these management interactions into a single monthly invoice review and a quarterly performance meeting.

Ownership TCO: the real numbers

The following analysis is based on a reference plant: a 500 m3/day industrial water treatment system producing process-quality water from municipal supply, with a simple treatment train of pretreatment, RO, and product storage, operating at a food or light-manufacturing facility in Western Europe. This is a representative mid-scale plant, not an edge case. Adjust the numbers proportionally for different scales.

Initial CAPEX: 800,000 to 1,400,000 euros. This covers the complete plant: pretreatment (multimedia filtration, coagulation and flocculation if required, softening), RO pressure vessels and membranes, high-pressure pumps, PLC/SCADA, product storage, piping, electrical supply, and commissioning. Civil works (building, concrete bases, drainage) are typically excluded from equipment quotes and add a further 80,000 to 200,000 euros. Engineering, procurement, and project management add 8 to 15% of equipment cost.

Annual OPEX: 120,000 to 200,000 euros per year at steady state. This includes:

• Staffing: 1 to 2 dedicated operators or operator time allocation from a maintenance team. 40,000 to 80,000 euros per year including employment costs, training, and on-costs.
• Energy: 4 to 12 kWh/m3 for RO depending on feed water TDS and recovery rate. At 0.15 euros/kWh and 500 m3/day, energy cost runs 55,000 to 165,000 euros per year. The reference plant assumes 8 kWh/m3, yielding approximately 88,000 euros per year.
• Chemicals: antiscalant, pH adjustment, biocide, CIP chemicals. Typically 0.10 to 0.30 euros/m3. For 500 m3/day, this runs 18,000 to 55,000 euros per year.
• Membranes and consumables: amortised replacement cost, including RO membranes replaced every 4 years, prefilter cartridges, UV lamps. Approximately 20,000 to 40,000 euros per year when amortised over the replacement cycle.
• Analytical and compliance: sampling, laboratory testing, consent reporting. 5,000 to 15,000 euros per year.

15-year capital replacement cost: 280,000 to 520,000 euros. This includes two full RO membrane replacement cycles (approximately 80,000 to 150,000 euros each), pump overhauls, softener resin replacement, instrumentation and control system upgrades, and mid-life refurbishment of pretreatment media. Many ownership models provision 50 to 100 euros per year per m3/day of capacity for planned maintenance reserve. The reference plant should be provisioning 25,000 to 50,000 euros per year in a maintenance reserve to cover these costs. Most do not.

Technology and regulatory upgrade allowance: 150,000 to 400,000 euros over 15 years. A conservative provision for one material regulatory upgrade event, such as tighter nutrient discharge limits or addition of a tertiary treatment stage for micropollutant removal. At the lower end: a modest consent tightening requiring chemical dosing adjustments and additional monitoring. At the upper end: addition of an advanced treatment stage or significant process redesign triggered by regulatory change.

15-year ownership TCO: 3,100,000 to 6,000,000 euros. Broken down: initial CAPEX 800,000 to 1,400,000 euros, plus civil works 80,000 to 200,000 euros, plus 15-year OPEX 1,800,000 to 3,000,000 euros, plus capital replacement 280,000 to 520,000 euros, plus regulatory upgrade provision 150,000 to 400,000 euros. The midpoint is approximately 4,500,000 euros over 15 years.

NPV at 8% discount rate: 2,200,000 to 4,200,000 euros. The CAPEX lands in year 1 (not discounted), ongoing OPEX and replacement costs are discounted at 8%, reflecting a typical industrial cost of capital. Facilities with higher cost of capital (12 to 15%, common in capital-constrained markets or highly leveraged businesses) show a materially higher NPV advantage for OPEX-only models.

WaaS TCO: what you pay and why

WaaS pricing for the reference 500 m3/day plant typically runs 1.50 to 3.50 euros per m3 of treated water delivered, depending on treatment complexity, contract length, feedwater quality, and the provider's cost of capital. For the reference plant:

• Service fee at 2.00 euros/m3, 500 m3/day, 350 operating days per year: 350,000 euros per year.
• 15-year total payment (assuming no inflation escalation for simplicity): 5,250,000 euros.
• With 2.5% annual escalation (typical CPI-linked provision in WaaS contracts): 15-year total rises to approximately 6,100,000 euros.

This is higher in absolute terms than the ownership midpoint before discounting. But the NPV comparison tells a different story.

WaaS NPV at 8% discount rate: 2,900,000 to 4,500,000 euros. The CAPEX is zero in year 1 for the facility. Future payments are discounted at 8%. Because most of the cost is deferred, and the discount rate is working in the customer's favour, the WaaS NPV is frequently within 15 to 25% of the ownership NPV for facilities with moderate cost of capital.

At higher discount rates, WaaS wins more clearly. At 12% discount rate (reflecting a capital-constrained organisation or a market where water treatment competes with high-return investment alternatives), the WaaS NPV advantage over ownership can be 20 to 35%. The 15-year WaaS contract that looks expensive per unit is frequently cheaper than the ownership model once you include the capital replacement cycle cost most finance teams do not provision for, and discount both models at a realistic cost of capital.

The comparison table below shows the full breakdown for the reference plant at 8% discount rate:

The key insight from this table: the ranges overlap. At the 500 m3/day scale with a mid-complexity treatment train, ownership and WaaS are financially close. The decision correctly turns on factors other than raw NPV: cost of capital, risk tolerance, management bandwidth, and balance sheet treatment. For larger plants (above 2,000 m3/day), the ownership economics improve significantly because fixed staffing costs are spread over a larger volume and the per-unit capital cost is lower. For smaller plants or those with high regulatory complexity, WaaS's risk transfer value is more material.

The World Bank's work on private sector participation in water infrastructure documents extensively how the financing structure for water assets affects total cost, and how public-private models consistently show that risk transfer to the operator rather than the asset owner produces better long-term maintenance outcomes. Industrial WaaS mirrors this logic at the facility scale.

When ownership wins: the threshold tests

Ownership produces the better long-run financial outcome when the following conditions are true.

High and stable water volume. For plants above 2,000 m3/day operating at high utilisation, the economics of ownership are substantially stronger. The fixed cost of staffing is amortised over a large volume, the per-unit CAPEX is lower because of scale efficiencies, and the WaaS provider's margin on a large contract is proportionally larger in absolute terms. A 5,000 m3/day plant run efficiently in-house with a competent team can produce water at 0.80 to 1.20 euros/m3 all-in. A WaaS provider for the same plant might charge 1.50 to 2.00 euros/m3. At that volume, the gap is 1,500 to 2,000 euros per day, or 525,000 to 700,000 euros per year.

Low cost of capital. Organisations with access to cheap capital (investment-grade credit, low-interest development bank finance, or strong balance sheet capital allocation at below 6% hurdle rate) find that the NPV disadvantage of front-loaded CAPEX is lower. The discounting math works against ownership at high discount rates and for ownership at low ones. If your cost of capital is 5%, ownership's NPV advantage over WaaS at high volume is more pronounced than if your cost of capital is 12%.

Water treatment as core competency. Pharmaceutical manufacturers who require ultrapure water at USP or EP standard, semiconductor manufacturers running ultrapure water systems, and beverage producers for whom process water quality directly determines product quality typically build and operate their own water treatment. They employ specialist engineers, have quality systems that require in-house control, and the volume and quality requirements mean they build real internal expertise. For these organisations, outsourcing the water treatment function is a loss of control at a production-critical point. The cost of ownership is the price of control, and it is worth paying.

Stable, well-understood regulatory environment. Sites operating in stable regulatory jurisdictions with long-standing consent conditions, low risk of tightening, and well-established compliance processes have lower regulatory uncertainty cost. The provision for regulatory upgrade in the TCO model can be low. This shifts the comparison toward ownership.

Long site life with confident future. An EPC contractor building a 20-year process plant at a greenfield site with a clear 25-year site plan is an appropriate ownership candidate. The organisation has a long enough horizon to fully amortise the capital, use all the capital replacement cycles, and benefit from the lower per-unit cost of owned operation. WaaS is particularly unattractive when the site life is long and certain, because you pay the WaaS provider's margin throughout.

When WaaS wins: the threshold tests

WaaS produces the better financial outcome when different conditions apply.

Capital constraint is real, not just a preference. Many businesses prefer OPEX to CAPEX because OPEX is off-balance-sheet in certain accounting treatments and because it avoids committing capital to infrastructure. But WaaS genuinely wins when capital is truly constrained: when the organisation is growing rapidly and has many high-return investment opportunities competing for capital, when the business is in a sector where water treatment capital has to compete against direct revenue-generating equipment, or when access to capital is structurally limited by leverage, covenant restrictions, or sector financing conditions. In these situations, the opportunity cost of the capital tied up in water treatment assets is real and large, and the WaaS model releases that capital for higher-value deployment.

Regulatory complexity is high and rising. Facilities handling produced water from oil and gas operations, operating effluent treatment plants under complex multi-parameter consents, or managing sewage treatment adjacent to regulated watercourses carry material regulatory upgrade risk. When the expected cost of regulatory compliance over 15 years is high and uncertain, transferring that risk to a WaaS provider who takes on the performance obligation is a financially rational decision even if the base case WaaS cost is higher. You are buying certainty, not just service.

Specialist labour is scarce or expensive. In markets where qualified water treatment operators are difficult to recruit and retain (tight labour markets, remote locations, sectors competing against large utilities and contractors for the same talent pool), the in-house staffing cost assumption in the ownership model is frequently understated. Legionella management and specialist membrane cleaning in ultrafiltration systems, nanofiltration, and complex RO trains requires expertise that commands premium wages and is genuinely scarce. When the realistic staffing cost is 20 to 30% higher than the benchmark because of market conditions, and when turnover risk means knowledge is repeatedly rebuilt, the WaaS model's fixed operational cost becomes more attractive.

Variable demand makes capital utilisation poor. A facility whose water demand varies significantly by season, production cycle, or product mix will have a capital-owned plant that sits at low utilisation during low-demand periods while still incurring fixed staffing and maintenance cost. WaaS priced per m3 scales naturally with demand. The crossover point depends on the minimum take or availability fee in the WaaS contract, but for facilities with demand variability above 40 to 50% between peak and trough, the utilisation argument for WaaS is real.

Site life is uncertain. An organisation considering a WaaS contract for a facility with an uncertain future (dependent on a single customer, subject to regulatory or market risk that could close the facility, or in a sector with structural overcapacity) should actively prefer WaaS. The exit provisions in a WaaS contract, while not costless, are less damaging than writing off 800,000 to 1,400,000 euros of stranded water treatment capital if the site closes in year 7.

If you are working through this threshold analysis and want structured input on which model fits your specific facility, post your project requirements on Aguato to receive financial comparisons from WaaS providers, O&M contractors, and EPC suppliers who operate in your sector.

Contract structure and due diligence for WaaS

The most important financial risk in a WaaS arrangement is not the unit price. It is the contract structure. A WaaS contract signed without rigorous legal and technical review can lock a facility into a 15 to 20 year commitment with inadequate performance protections, no exit pathway, and a price escalation mechanism that delivers materially higher costs than the base case projection.

Performance specification: outputs, not inputs. The WaaS contract must specify the required outputs: treated water quality (temperature, TDS, pH, specific ions, microbiological standard), volume availability (m3/day guaranteed, minimum availability percentage), and reliability (maximum allowable downtime hours per period). The contract should not specify the technology or operating method because that constrains the provider's ability to optimise or upgrade. But it must be specific on what you receive. A contract that specifies "potable-quality water" without defining the analytical standard it must meet will be interpreted to the minimum standard the provider can defend.

Price escalation mechanisms. WaaS contracts typically include price escalation tied to one or more indices: CPI, energy price indices (because energy is a major operating cost for membrane systems), or labour indices. The compounding effect of escalation over 15 to 20 years is large. A contract starting at 2.00 euros/m3 with 3% annual escalation reaches 3.12 euros/m3 by year 15. Model the full escalation trajectory before signing. Understand which cost elements are indexed to what and whether there is a cap on annual escalation. An uncapped energy index escalation clause in a contract signed before a period of high energy prices can produce large cost shocks.

Minimum take or availability fees. Most WaaS contracts include either a minimum annual volume commitment or an availability fee that you pay regardless of actual water consumption. This protects the provider's revenue during low-demand periods. Understand the minimum take level and compare it to your realistic demand variability. If your minimum demand is 60% of the volume on which the contract is priced, the per-unit cost in low-demand periods rises substantially.

Technology refresh obligations. A 20-year WaaS contract needs to address what happens when the technology at year 0 is no longer fit for purpose at year 12. Does the provider have the obligation to upgrade the treatment technology if required to maintain the specified performance? At whose cost? What triggers the upgrade obligation? Contracts that are silent on technology refresh put the facility operator in the position of being locked into an underperforming technology because the WaaS provider has no contractual obligation to invest in upgrades.

Exit provisions and step-in rights. The exit provisions of a WaaS contract determine the financial exposure if the relationship does not work. Key provisions: what are the termination for convenience costs (the penalty for early exit)? What happens if the WaaS provider becomes insolvent or is acquired? Does the facility have step-in rights that allow it to take over plant operation if the provider is not meeting performance obligations? Who owns the plant at contract end, and at what price? The step-in right is particularly important: a facility whose water supply is entirely dependent on a WaaS provider with no contractual step-in right has no operational recovery pathway if the provider fails.

Browse engineering consultants on Aguato who specialise in WaaS contract review and structuring if you are at the term-sheet stage of a WaaS negotiation. Independent technical review before signing a 15-year contract costs a fraction of the legal and operational exposure of a poorly structured agreement.

Failure modes and what they cost

Both models have characteristic failure modes. Understanding them in advance and pricing them into the financial model changes the comparison in ways that are uncomfortable but accurate.

Ownership failure mode 1: The deferred maintenance spiral. The most common ownership failure is deferred maintenance. A plant that should spend 30,000 to 50,000 euros per year on planned maintenance consistently defers this cost when budgets are tight, because the plant appears to be running and the cost is discretionary in the short term. By year 8 to 10, multiple subsystems are approaching failure simultaneously. The catch-up capital requirement is 200,000 to 500,000 euros concentrated in a two to three year period. This is the event that most internal financial models do not provision for. The World Bank's analysis of privately financed water infrastructure consistently finds that publicly owned and operated industrial water systems show a higher rate of deferred maintenance and a higher incidence of unplanned capital events than contractor-operated systems.

Ownership failure mode 2: Operator loss at a critical moment. The plant's lead operator resigns three months before a regulatory inspection, taking with them the institutional knowledge of the consent conditions, the monitoring protocol, and the CIP procedure for the RO membranes. The organisation spends 40,000 to 80,000 euros on consultants to reconstruct the operational knowledge base, misses two analytical reporting windows, and receives a compliance notice from the regulator. The direct cost of this event is 60,000 to 120,000 euros. The indirect cost (management time, regulatory scrutiny, production disruption) can be two to three times higher.

Ownership failure mode 3: Regulatory upgrade with insufficient capital provision. The environmental regulator tightens the nitrogen limit in the site's discharge consent, requiring addition of a biological treatment stage or an advanced oxidation process. The capital cost is 350,000 euros. The organisation did not provision for this event, the capital budget for the year is committed, and the consent deadline is 18 months away. The resulting choices are all bad: expensive emergency financing, missed consent deadline with regulatory penalty, or production curtailment. Provision for this risk at 15,000 to 25,000 euros per year from contract start converts this from a crisis to a managed event.

WaaS failure mode 1: Provider financial distress. The WaaS provider that designed and built the plant on your site enters administration in year 11. You do not own the plant. You have no trained operators. The plant is technically complex. Without contractual step-in rights and a maintenance of performance bond or parent company guarantee, you have a water supply disruption that takes 3 to 6 months and 200,000 to 400,000 euros to resolve. This risk can be managed: contractual step-in rights, performance bonds, escrow of as-built drawings and operating manuals, and a qualified second-source operator on retainer are the standard risk mitigants. But they must be in the contract before it is signed.

WaaS failure mode 2: Price escalation beyond projection. A WaaS contract signed with an uncapped energy index escalation clause in 2019 reached costs 35 to 50% above the year-1 base rate by 2023 in many European markets due to energy price increases. The facility had no exit right for price reasons and no budget provision for cost overrun at this scale. Capped escalation (maximum 3 to 5% per year regardless of index) or fixed-proportion escalation (energy component indexed, non-energy component fixed) prevents this outcome. Review escalation clause structure as carefully as the base price.

WaaS failure mode 3: Performance specification drift. The facility's process changes over time: a new product line changes water quality requirements, increased production volumes push demand above the contracted volume, or a process change generates a more challenging effluent. If the WaaS contract specified performance against original requirements, the provider has no obligation to accommodate the changed requirements without renegotiation and likely price adjustment. This is not a failure of the WaaS model; it is a failure to provision for operational flexibility in the contract. Include change-in-scope procedures with pre-agreed pricing mechanisms for volume and quality changes within a defined range.

The CFO Hook

Here is what the financial analysis of water treatment ownership versus WaaS actually shows, stated plainly.

The ownership model is usually not as cheap as the financial model says it is. The four cost categories that are systematically excluded from internal ownership financial models, capital replacement cycles, regulatory upgrade provisions, compliance event expected value, and management opportunity cost, add 20 to 40% to the true 15-year ownership TCO at the 500 m3/day scale. If your ownership model looks substantially cheaper than the WaaS quote, the first question to ask is which of these categories are you not including.

The WaaS model is not as expensive as the sticker price implies. A WaaS quote of 2.00 euros/m3 for a 500 m3/day plant looks like 350,000 euros per year against a steady-state ownership OPEX of perhaps 160,000 euros per year and tempts the conclusion that WaaS costs twice as much. It does not. The ownership model also has 1.0 to 1.4 million euros of CAPEX in year 1, capital replacement costs spread through years 4 to 12, and regulatory upgrade exposure. NPV both models at your actual cost of capital before concluding.

The financial comparison frequently does not determine the right answer. For many industrial facilities operating at the 200 to 2,000 m3/day scale, the 15-year NPVs of ownership and WaaS are within 20 to 30% of each other, and within that band, the right answer depends on factors that do not appear in a financial model: organisational capability to manage and retain a specialist operating team, regulatory risk profile, corporate balance sheet strategy, and the quality of the available WaaS providers in the market. These are strategic decisions, not financial calculations.

WaaS providers sell predictability. That has a price. Whether that price is worth paying depends on your cost of capital, your regulatory risk exposure, and your ability to attract and retain specialist operators over a 20-year plant life. The analysis in this article gives you the framework to answer that question with numbers rather than instinct.

For a structured comparison specific to your facility, including technology selection, capacity planning, and financial modelling support, use the Aguato decision tool or browse WaaS and O&M providers on Aguato by service type and geography.

The connected financial decision, whether to structure the investment as capital expenditure or operating expenditure regardless of operating model, is covered in Water Treatment CAPEX vs OPEX.

Related articles

• Water Treatment Plant O&M: Build vs Buy vs Outsource - the operating model decision
• Water Treatment CAPEX vs OPEX - financial structure analysis
• Industrial Wastewater Discharge Regulations - compliance cost drivers
• Zero Liquid Discharge Systems - maximum-treatment investment decisions
• Effluent Treatment Plant Design - ETP capital and operating cost context

FAQ

How long does a typical WaaS contract run, and what happens at the end?

WaaS contracts typically run 15 to 20 years. This duration reflects the time the provider needs to amortise the capital invested in designing and building the plant. At contract end, the most common outcomes are: the plant transfers to the facility owner at a pre-agreed residual value (often close to zero if fully amortised); the contract is renewed under updated commercial terms; or the provider removes the plant if it has residual value and can be redeployed. Contract end treatment should be agreed at the time of signing, not renegotiated at year 18 when your negotiating position is weak. Facilities should specify in the contract whether they want a purchase option at contract end, at what price basis, and how the final 3 to 5 years of asset condition maintenance will be governed to prevent end-of-contract underinvestment.

What size plant makes WaaS economically viable?

WaaS providers generally require a minimum treated water volume of 150 to 300 m3/day to make the economics work at standard pricing. Below this threshold, the fixed cost of the provider's capital, project management, and ongoing account management cannot be spread across sufficient volume to support a competitive per-unit price, and the plant is typically too small to justify the provider's overhead of contract management over 15 years. Above 5,000 m3/day, ownership economics are usually strong enough that WaaS unit pricing cannot compete with well-run in-house operation at full scale. The sweet spot for WaaS is typically 300 to 3,000 m3/day for standard industrial applications.

Is WaaS ever classed as a lease under IFRS 16, and does that affect the off-balance-sheet benefit?

Yes, WaaS contracts can be caught by IFRS 16 if they give the customer the right to control the use of the identified asset. If the WaaS contract specifies a particular plant at a particular site and the customer directs how and when the asset is used, IFRS 16 may require the customer to recognise a right-of-use asset and a corresponding lease liability on-balance-sheet. Well-structured WaaS contracts avoid IFRS 16 classification by ensuring the provider retains operational control over how the plant operates and can substitute equipment, retaining the service character of the arrangement. This is both a legal and an accounting structuring issue and should be reviewed with the organisation's auditors before signing. The off-balance-sheet benefit that WaaS is frequently marketed on depends on this classification being correct.

What costs does the WaaS service fee typically not include?

WaaS service fees almost always exclude: feedwater supply (the connection to mains, borehole, or raw water source is your cost); power supply to the plant (the provider uses it, but you pay the electricity bill unless energy is bundled into the fee, which some providers offer); site integration costs (piping from the plant to your process, product storage if above what is included in the plant scope, civil works for the plant footprint); regulatory permit fees and consent charges (the plant operator may be the provider, but the regulated site is yours); and any produced water disposal or brine disposal costs (these are your responsibility unless explicitly contracted). Always scope the full cost of the arrangement including excluded items before comparing to the full cost of ownership.

How should we structure the WaaS performance guarantee to protect against poor service?

The performance guarantee should be structured around output specifications (water quality parameters and volume availability) rather than process specifications, financial penalties sufficient to make compliance economically dominant over non-compliance, a response time obligation for performance breaches with escalating consequences for sustained underperformance, a step-in right allowing you to engage a third-party operator at the WaaS provider's cost if they fail to restore performance within a defined period, and a termination for persistent breach right that allows you to exit the contract without paying termination compensation if the provider has failed to meet performance obligations for a sustained period. The penalty scale matters: a penalty of 2% of the monthly fee for a compliance breach that causes you 50,000 euros of regulatory exposure and production disruption creates no real incentive. Penalties should be calibrated to the actual cost of the breach to you, not to a fraction of the provider's monthly revenue.

How does WaaS compare to ownership for zero-liquid-discharge or complex industrial effluent treatment?

For zero-liquid-discharge systems and complex effluent treatment plants, the WaaS model becomes more attractive relative to ownership than for simple water production. The reasons: ZLD and complex ETP capital costs are much higher (2.5 to 8 million euros for a 500 m3/day ZLD system versus 800,000 to 1,400,000 for a standard RO), the technology is evolving faster which increases obsolescence risk for owners, the specialist operating expertise required is considerably scarcer and more expensive, and the regulatory risk is typically higher. WaaS providers for ZLD and complex ETP exist but are fewer in number and more selective about projects. The threshold tests for WaaS still apply, but the magnitude of the risk transfer value is larger, which shifts the NPV comparison more favourably toward WaaS even at higher unit prices. Use the Aguato provider directory to find WaaS providers with ZLD and complex ETP capability.